During the progression of illness in patients and depending on the infecting DENV serotype and previous exposure of the patient to the virus, anti-dengue antibodies (IgM and IgG) will continue to increase and may influence viral profiles in the patient and affect mosquito susceptibility by neutralizing DENV and preventing virus infection of the midgut [37]. This evidence concerns the gene CD40LG and viral infectious disease.